Europe Allergy Diagnostics Market (2026-2031)
The Europe Allergy Diagnostics Market was valued at $302.07 Million in 2026 and projected to reach to $500.93 Million by 2031, representing a compound annual growth rate of 10.6%. Europe's allergy diagnostics market is positioned for sustained growth through 2031, supported by rising environmental allergen exposure, increased healthcare spending, and growing patient awareness of allergic conditions.
Europe Allergy Diagnostics Market Trends and Insights
- Rest Of Asia Pacific represents a high-growth region driven by rising allergy prevalence, increasing healthcare awareness, and expanding diagnostic infrastructure across emerging economies.
- The region's growth trajectory outpaces global benchmarks, reflecting strong demand for both in-vivo and in-vitro allergy testing solutions. Rest Of Asia Pacific's market dynamics are shaped by improving access to diagnostic technologies, growing middle-class populations, and rising investment in healthcare systems.
- Between 2026 and 2031, Rest Of Asia Pacific is expected to capture significant market share through adoption of advanced immunoassay platforms and molecular diagnostic methods.
- Healthcare providers in Rest Of Asia Pacific are increasingly prioritizing early allergy detection and personalized treatment approaches, supporting sustained market expansion throughout the forecast period..
Key Market Statistics
- CAGR (2026-2031) 10.6% CAGR
- Market Size, 2026 ~USD 302.07 Million
- Forecast, 2031 ~USD 500.93 Million
- Geography Europe
Europe Allergy Diagnostics Market Overview
Market Leadership :
Europe commands a significant share of the global allergy diagnostics market, with Germany leading at USD 430.5 million, followed by the UK at USD 405.7 million, reflecting strong healthcare infrastructure and diagnostic adoption.
Robust Growth Trajectory :
The European market is expanding at a CAGR of 10.6%, outpacing the global average of 9.6%, driven by increasing allergy prevalence, stringent regulatory standards, and advanced healthcare systems across major economies.
Diverse Market Composition :
Europe's allergy diagnostics landscape includes major markets like France (USD 328.5 million), Italy (USD 221.5 million), and Spain (USD 188.8 million), alongside the Rest of Europe segment valued at USD 838.3 million, indicating widespread market penetration.
Forecast Growth Potential :
The European market is projected to grow from USD 302.07 million in 2026 to USD 500.93 million by 2031, representing substantial investment opportunities in diagnostic technologies, immunoassays, and point-of-care testing solutions.
Europe Allergy Diagnostics Market Dynamics
- The region's mature healthcare infrastructure and regulatory frameworks facilitate rapid adoption of innovative diagnostic technologies, including molecular testing and component-resolved diagnostics.
- Major European economies are investing in allergy management programs and preventive healthcare initiatives, further driving market expansion. The competitive landscape in Europe is characterized by strong presence of established diagnostic manufacturers and emerging innovators focusing on personalized medicine and digital health integration.
- Regulatory harmonization through EU directives and CE marking requirements ensures quality standards while enabling market access.
- Strategic partnerships between diagnostic companies and healthcare providers, coupled with reimbursement improvements, are expected to accelerate market penetration across both developed and emerging European markets through 2031..
Related Ecosystem
In Vitro Diagnostics
- Polymerase Chain Reaction (PCR)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Dna Microarrays
- Assay Kits
- Microarrays
- ROCHE HOLDINGS AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abbott Laboratories
- Biomerieux s.a.
Key Takeaways
- Rest Of Asia Pacific allergy diagnostics market valued at USD 302.07 million in 2026, expanding to USD 500.93 million by 2031 at 10.6% CAGR
- Rest Of Asia Pacific growth rate exceeds global average, driven by rising allergy incidence and healthcare infrastructure development
- Rest Of Asia Pacific demand for advanced diagnostic platforms including immunoassays and molecular testing is accelerating across emerging markets
- Rest Of Asia Pacific market expansion supported by increasing healthcare spending, regulatory improvements, and growing patient awareness of allergy management
Allergy Diagnostics Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | IN VITRO TESTS (Test Type) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 9.6% from 2026 to 2031 |
| Largest Segment | CONSUMABLES (Product & Service) |
| Market Size Base Year (Billions) | ~USD 6.81 (2026) |
| Revenue Forecast (Billions) | ~USD 10.77 (2031) |
| Segments Covered | Product & Service, Type, Test Type, Allergen, End User |
Europe Allergy Diagnostics Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product & Service
- Consumables
- Instruments
- Services
By Type
- Immunoassay Analyzers
- Luminometers
- Other In Vivo Tests
- Other Instruments
- Patch Tests
- Skin Prick Tests
By Test Type
- In Vitro Tests
- In Vivo Tests
By Allergen
- Drug Allergens
- Food Allergens
- Inhaled Allergens
- Other Allergens
By End User
- Academic Research Institutes
- Diagnostic Laboratories
- Hospital-Based Laboratories
- Other End Users
Target Audience
- Diagnostic Manufacturers : In vitro diagnostics and allergy testing companies need European market data to identify expansion opportunities, assess competitive positioning, and develop region-specific product strategies.
- Healthcare Providers & Laboratories : Hospitals, diagnostic laboratories, and allergy clinics require market intelligence to optimize service offerings, justify capital investments in diagnostic equipment, and enhance patient care delivery.
- Investors & Private Equity : Investment firms evaluating opportunities in European healthcare diagnostics need comprehensive market sizing, growth projections, and competitive analysis to support M&A and funding decisions.
- Pharmaceutical & Biotech Companies : Allergy medication and immunotherapy developers require market context on diagnostic adoption rates and patient segmentation to align therapeutic development with diagnostic capabilities.
- Healthcare Policy & Regulatory Bodies : Government health agencies and regulatory organizations use market data to inform reimbursement policies, healthcare infrastructure planning, and allergy management program development across Europe.
Key Companies in the Europe Allergy Diagnostics Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| TECAN GROUP LTD. | Switzerland |
TECAN GROUP LTD.
TECAN GROUP LTD. is a Swiss life sciences company providing laboratory automation and diagnostic instruments.
Countries within Europe - compare and drill down
| Country | 2025 size (native) |
|---|---|
| Germany | USD 430.5 Million |
| UK | USD 405.7 Million |
| France | USD 328.5 Million |
| Italy | USD 221.5 Million |
| Spain | USD 188.8 Million |
| Rest Of Europe | USD 838.3 Million |
Country market size visualization
Reasons to Buy this Report
- Country-Level Market Insights : Gain detailed market sizing and growth projections for key European markets including Germany, UK, France, Italy, and Spain, enabling targeted market entry and expansion strategies.
- Competitive Landscape Analysis : Understand the competitive positioning of diagnostic manufacturers across Europe, identify market gaps, and benchmark against regional leaders to optimize product development and commercialization.
- Regulatory & Reimbursement Framework : Access comprehensive insights into European regulatory requirements, CE marking pathways, and reimbursement policies that directly impact market access and pricing strategies.
- Growth Driver Identification : Identify key growth catalysts specific to Europe including rising allergy prevalence, healthcare digitalization, and preventive medicine trends to inform strategic investment decisions.
- Forecast-Driven Planning : Leverage 2026-2031 market forecasts and CAGR projections to develop long-term business strategies, resource allocation plans, and revenue growth targets for European operations.
Frequently asked questions
What is the market size of allergy diagnostics in Rest Of Asia Pacific?
Rest Of Asia Pacific allergy diagnostics market is valued at USD 302.07 million in 2026 and is projected to reach USD 500.93 million by 2031.
What is the CAGR for Rest Of Asia Pacific allergy diagnostics market?
Rest Of Asia Pacific allergy diagnostics market is expected to grow at a compound annual growth rate (CAGR) of 10.6% from 2026 to 2031.
What factors are driving growth in Rest Of Asia Pacific allergy diagnostics?
Rest Of Asia Pacific growth is driven by rising allergy prevalence, expanding healthcare infrastructure, increasing diagnostic awareness, and growing investment in healthcare systems across emerging economies.
Which diagnostic technologies are gaining traction in Rest Of Asia Pacific?
Rest Of Asia Pacific markets are increasingly adopting advanced immunoassay platforms, molecular diagnostic methods, and in-vitro testing solutions for improved allergy detection and personalized treatment.
How does Rest Of Asia Pacific compare to global allergy diagnostics growth?
Rest Of Asia Pacific's 10.6% CAGR outpaces the global average of 9.6%, positioning the region as a high-growth market with significant expansion potential through 2031.
RESEARCH METHODOLOGY
The study involved major activities in estimating the current market size for the global Allergy Diagnostic market. Exhaustive secondary research was done to collect information on the allergy diagnostic market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market sizes of the allergy diagnostic market's segments and subsegments.
Secondary Research
This research study involved the wide use of secondary sources, directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, Factiva, whitepapers, and companies’ in-house documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the allergy diagnostic market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various supply- and demand-side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, VPs/managing directors, marketing heads/directors and sales directors, marketing/sales managers, regional/area sales managers, export/import heads/managers, and other market-related personnel from various companies and organizations operating in the allergy diagnostic market. Primary sources from the demand side included vice presidents in hospitals & clinics, C-level executives, department heads, doctors/physicians, hospital supply management teams, clinic personnel, and laboratory technicians.
Breakdown of Primary Interviews
Note 1: C-level primaries include CEOs, COOs, and CTOs.
Note 2: Others include sales managers, marketing managers, and product managers.
Note 3: Companies are classified into tiers based on their total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3 = <USD 500 million
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the allergy diagnostic market. These methods were also widely used to estimate the sizes of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Data Triangulation
The market was divided into four segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the market engineering process and arrive at precise statistics for all segments.
Approach to derive the market size and estimate market growth: Using secondary data from paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of allergy diagnostic products. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.
Market Definition
Allergy testing helps determine the substances causing a patient's allergy symptoms. Tests include skin tests, intradermal tests, challenge tests, blood tests, and patch tests. Allergists commonly conduct challenge tests, including food, inhalation, drug, and physical challenges. Blood tests are generally used when unsafe or unapplicable skin tests are required, such as when consuming certain medications or having a skin condition that may interfere with skin testing. Allergy tests, such as in vitro & in vivo tests, are performed to determine the cause, stage, prognosis, and treatment course for allergic diseases.
Key Stakeholders
- Allergy Diagnostic Reagents, Kits, and Instrument Manufacturers
- Allergy Diagnostic Vendors and Distributors
- Hospitals
- Diagnostic Laboratories
- Allergy Diagnostic Service Providers
- Academic Research Institutes
- Venture Capitalists and Investors
- Contract Research Organizations (CROs)
Report Objectives
- To describe, analyze, and forecast the allergy diagnostic market, by product & service, test type, allergen, end user, and region
- To describe and forecast the allergy diagnostic market for key regions, namely, North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries
- To provide detailed information regarding drivers, restraints, opportunities, and challenges influencing the growth of the allergy diagnostic market
- To strategically analyze the ecosystem, regulations, patenting trend, value chain, Porter’s Five Forces, and prices pertaining to the market under study
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
- To profile key players and comprehensively analyze their market shares and core competencies in the allergy diagnostic market
- To analyze competitive developments such as collaborations, acquisitions, product launches, expansions, and R&D activities in the allergy diagnostic market
Available customizations:
With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to 5)
Product Analysis
- Product matrix, which gives a detailed comparison of the product portfolios of each company
Geographic Analysis
- Further breakdown of the Rest of Asia Pacific allergy diagnostic market into Vietnam, New Zealand, and others
- Further breakdown of the Rest of Latin America allergy diagnostic market into Colombia, Chile, Ecuador, and others
- Further breakdown of the Rest of Europe allergy diagnostic market into Belgium, Russia, the Netherlands, Switzerland, and others
Get the Full Allergy Diagnostics Market Report
Full forecast, segment splits, and company analysis for all Allergy Diagnostics Market.
- Canada Allergy Diagnostics Market
- US Allergy Diagnostics Market
- Germany Allergy Diagnostics Market
- UK Allergy Diagnostics Market
- France Allergy Diagnostics Market
- Italy Allergy Diagnostics Market
- Spain Allergy Diagnostics Market
- China Allergy Diagnostics Market
- Japan Allergy Diagnostics Market
- India Allergy Diagnostics Market
- South Korea Allergy Diagnostics Market
- Australia Allergy Diagnostics Market
- Brazil Allergy Diagnostics Market
- Mexico Allergy Diagnostics Market
- GCC Countries Allergy Diagnostics Market
- Rest Of Europe Allergy Diagnostics Market
- Rest Of Asia Pacific Allergy Diagnostics Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report